PPT-Digoxin And Mortality in Patients With Atrial Fibrillation

Author : ellena-manuel | Published Date : 2017-08-16

Renato D Lopes MD PhD FACC on behalf of the ARISTOTLE Investigators Disclosures The ARISTOTLE trial was sponsored by BristolMyers Squibb and Pfizer The present

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Digoxin And Mortality in Patients With A..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Digoxin And Mortality in Patients With Atrial Fibrillation: Transcript


Renato D Lopes MD PhD FACC on behalf of the ARISTOTLE Investigators Disclosures The ARISTOTLE trial was sponsored by BristolMyers Squibb and Pfizer The present analysis was sponsored by . fibrillation: diagnosis and management. د. حسين محمد جمعة . اختصاصي الامراض الباطنة . البورد العربي . كلية طب الموصل . 2010. de la Fibrillation . Auriculaire. en . Pratique. de Ville. Samer. Nasr, M.D.. Mount Lebanon Hospital.. Classification. Lone . atrial. fibrillation:. Younger than 60 years old.. No clinical or echo evidence of cardiopulmonary disease.. Rhea C. Pimentel, MD. Associate Professor of Medicine. Fellowship Program Director, Clinical Cardiac Electrophysiology Program. Disclosures. Speakers Bureau: Medtronic. Speakers Bureau: St. Jude Medical. A U G U S T 2 0 1 4. Physicians. 2. Physicians. A majority of physicians believe most Atrial Fibrillation patients don’t usually understand their increased risk of stroke and feel most patients underestimate the impact ischemic stroke can have on their lives. . Martha Drake MS, FNP-BC. Chicago Heart and Vascular Consultants, LTD. Purdue Northwest Doctorate of Nursing Program. Learning Objectives. Discuss the incidence of atrial fibrillation (AF) in the population. . John Windle MD October 18, 2013. Professor and Chief of Cardiology. University of Nebraska Medical Center. “Ha . ha. . ha. , Biff. Guess what? After we go to the drugstore and the post office, . Renato D. Lopes, MD, PhD, FACC. on behalf of the ARISTOTLE Investigators. Disclosures. The ARISTOTLE trial was sponsored by Bristol-Myers Squibb and Pfizer.. The present analysis was sponsored by the . <1% of individuals aged 60 to 65 years . 8% to 10% of individuals aged >80 years . Men more than women . White persons more than black persons. Presence and severity of underlying heart disease increases risk . . John Windle MD October 18, 2013. Professor and Chief of Cardiology. University of Nebraska Medical Center. “Ha . ha. . ha. , Biff. Guess what? After we go to the drugstore and the post office, . Dott. Giovanni Carreras. U.O.S.Aritmologia . Ospedale S. Maria . Terni. . • The most common significant heart rhythm disturbance. • Incidence increases with age and the development of structural heart disease . Carlos Calle-Muller, MD. Cardiac Electrophysiology. 734-855-9448. Objectives. To recognize the risks for patients with atrial fibrillation. To familiarize with the management of atrial fibrillation. Atrial fibrillation (AF) is the most common cardiac arrhythmia . page ITC6-2 Treatmentpage ITC6-6 Practice Improvementpage ITC6-14 Tool Kitpage ITC6-14 page ITC6-15 page ITC6-16 Deborah Cotton, MD, MPHDarren Taichman, MDSankey Williams, MDPhysician WriterThe conten Sodium channel blockers. Their . use . has . declined due to their . proarrhythmic. effects, particularly in patients with reduced left ventricular function and atherosclerotic heart disease. .. Class . ischaemic. attack in patients with. a diagnosis of resolved atrial fibrillation: . retrospective cohort. . studies.. Nicola J Adderley, . Krishnarajah. . Nirantharakumar. , Tom Marshall.. BMJ 2018.

Download Document

Here is the link to download the presentation.
"Digoxin And Mortality in Patients With Atrial Fibrillation"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents